Display Settings:

Format

Send to:

Choose Destination

    Br J Ophthalmol. 2005 Aug;89(8):976-82.

    Multifocal ERG in ethambutol associated visual loss.

    Behbehani RS, Affel EL, Sergott RC, Savino PJ.

    Neuro-ophthalmology Service, Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA 19107, USA. r_behbehani@hotmail.com

    AIM: To determine the anatomical site and extent of electrophysiological dysfunction in patients with ethambutol associated visual loss. METHODS: A comparative case series. Four patients with ethambutol associated visual loss underwent multifocal electroretinography (mERG). Two patients had advanced visual loss while two had early signs of toxicity. The N1-P1, N1, P1 amplitudes, N1, and P1 latencies were compared to 10 age and sex matched controls. RESULTS: mERG abnormalities were detected in the ethambutol treated patients. The N1 amplitude was significantly lower in the ethambutol treated patients than in the control group. CONCLUSION: Ethambutol is possibly toxic to the retina, and not only the optic nerve. The multifocal ERG may be of value to diagnose and monitor patients taking ethambutol.

    PMID: 16024847 [PubMed - indexed for MEDLINE]

    PMCID: 1772772

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Ethambutol (Myambutol®)

      Ethambutol eliminates certain bacteria that cause tuberculosis (TB). It is used with other medicines to treat tuberculosis and to prevent you from giving the infection to others.